MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dyskinesias"

  • MDS Virtual Congress 2020

    Opicapone in fluctuating Parkinson’s disease: The daily clinical practice

    L. Armengou Garcia, G. Martí-Andrés, R. Valentí Azcárate, I. Esparragosa Vázquez, C. Toledano Illán, R. Villino Boquete, R. Luquin (Pamplona, Spain)

    Objective: To evaluate the effectiveness, tolerability and safety of opicapone as add-on to levodopa (LD) in the daily clinical practice in fluctuating Parkinson’s disease (PD)…
  • MDS Virtual Congress 2020

    Home videos made on smart phone supplements paper based diary for correct identification of Motor states in Parkinson’s disease

    D. Dash, R. Singh, D. Vibha, M. Tripathi (Delhi, India)

    Objective: We aimed to assess the feasibility of home videos made on smart phone as a supplemental tool to paper based diary in registering the…
  • MDS Virtual Congress 2020

    Altered interhemispheric synchrony in Parkinson’s disease patients with levodopa-induced dyskinesias

    C.T Gan, M. Wang, QQ. Si, Y.S Yuan, Y. Zhi, L.N Wang, K.W Ma (Nanjing, China)

    Objective: Our investigation aimed to explore interhemispheric functional alterations and its corresponding morphological synchronization changes. Background: Levodopa-induced dyskinesias are common motor complication of Parkinson’s disease…
  • MDS Virtual Congress 2020

    Combined therapy VS only levodopa therapy in a 5-years follow up cohort

    C. Borrue-Fernandez, J. Alvarez -Alberca (San Sebastian Reyes, Spain)

    Objective: Describe the frequencies of appearance of motor fluctuations, impulse control disorders, in two therapeutic regimes: combined therapy (levodopa plus an other antiparkinsonian drug) or…
  • MDS Virtual Congress 2020

    Real-World Evidence for a Smartwatch-based Parkinson’s Motor Assessment App in Patients Undergoing Therapy Changes

    A. Hadley, D. Riley, D. Heldman (Cleveland, OH, USA)

    Objective: We sought to investigate patient and clinician usability of a smartwatch-based wearable motor assessment system for measuring Parkinson’s disease (PD) motor symptoms in patients undergoing…
  • MDS Virtual Congress 2020

    Levodopa-induced dyskinesias and substantia nigra dopamine D3 receptor availability in Parkinson’s disease

    G. Pagano, S. Molloy, P. Bain, E. Rabiner, K. Chaudhuri, D. Brooks, N. Pavese (Basel, Switzerland)

    Objective: To investigate with PET and the radioligand [11C]PHNO whether levodopa-induced dyskinesias in Parkinson disease (PD) are associated with dopamine-D3 receptor (D3R) overexpression in substantia nigra…
  • MDS Virtual Congress 2020

    Efficacy and tolerability of opicapone in Parkinson´s disease in usual clinical practice

    V. Gomez-Mayordomo, F. Alonso-Frech, E. Lopez-Valdes, R. Garcia-Ramos, M. Catalan-Alonso (Madrid, Spain)

    Objective: To evaluate the efficacy and tolerability of opicapone in usual clinical practice in patients with Parkinson's disease (PD). Background: Opicapone is a recently approved…
  • MDS Virtual Congress 2020

    Smartphone-based context awareness to improve ambulatory Parkinson’s monitoring

    A. Hadley, B. Walter, A. Espay, D. Heldman (Cleveland, OH, USA)

    Objective: To determine the utility of context-awareness algorithms based on sensors in smartphones to improve ambulatory Parkinson’s disease (PD) monitoring. Background: Previous research shows that optimal motion sensor-based ambulatory PD monitoring requires multiple sensors to…
  • MDS Virtual Congress 2020

    Abnormal network interconnections dynamics correlate with levodopa-induced dyskinesia in Parkinson’s disease

    Q. Si, Y. Yuan, C. Gan, M. Wang, L. Wang, K. Ma, K. Zhang (Nanjing, China)

    Objective: To explore the pathogenesis of dyskinesia, the present study was conducted to investigate that how large-scale functional network interactions change dynamically in the temporal…
  • MDS Virtual Congress 2020

    Impact of dopamine 2/3 receptor agonists on the phenomenology of L-DOPA-induced dyskinesia in patients with Parkinson’s disease

    S. Grigoriou, S. Christiansson, P. Odin, M.A Cenci (Lund, Sweden)

    Objective: To investigate possible differences in phenomenology and temporal profile of dyskinesias in patients with Parkinson’s disease (PD) after challenge doses with levodopa alone or…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 49
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley